Sulfur Containing Compound Database
Gene name | CYP71A12 |
AGI ID | AT2G30750 |
Gene length | 497 |
Uniprot ID | O49340 |
Protein Name | Cytochrome P450 71A12 |
Synonym | T11J7.14 |
EC number | EC 1.14.-.- |
Entrez Gene | 817626 |
Refseq mrna | NM_128628 |
Refseq protein | NP_180633 |
Function | Camalexin biosynthesis was induced in infected roots of both Col-0 (susceptible) and Bur-0 (partially resistant) accessions during the secondary phase of infection. However, the level of accumulation was four-to-seven times higher in Bur-0 than Col-0. This was associated with the enhanced transcription of a set of camalexin biosynthetic P450 genes in Bur-0: CYP71A13, CYP71A12, and CYP79B2 (Lemarié et al 2015) |
Group | Camalexin biosynthesis |
Reference | Lemarié et al. (2015); Wang et al. (2012); Saga et al. (2012); Nafisi et al. (2007); Glawischnig et al. (2004); Müller et al. (2015); Møldrup et al. (2013) |
Organism | AGI ID | Gene Name | Protein Name | Identity | E-Value | Description |
---|---|---|---|---|---|---|
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
49.364 |
3.52E-131 |
||
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
49.156 |
1.13E-124 |
||
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
43.958 |
1.56E-117 |
||
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
40.385 |
5.49E-109 |
||
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
40.084 |
6.31E-102 |
||
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
40.678 |
1.21E-101 |
||
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
40.252 |
1.60E-96 |
||
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
42.897 |
4.94E-79 |
||
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
47.525 |
6.14E-56 |
||
Papaya |
CYP71A12 |
Cytochrome P450 71A12 |
43.519 |
6.79E-52 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
79.661 |
0 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
61.783 |
0 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
57.872 |
1.60E-168 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
52.414 |
2.37E-141 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
48.401 |
8.92E-141 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
47.356 |
3.09E-134 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
60.806 |
1.22E-107 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
40.598 |
3.82E-103 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
40.558 |
2.07E-102 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
43.852 |
1.47E-95 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
42.017 |
2.17E-94 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
40.336 |
1.62E-93 |
||
Broccoli |
CYP71A12 |
Cytochrome P450 71A12 |
55.932 |
6.18E-60 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
81.087 |
0 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
61.474 |
0 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
61.311 |
0 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
61.229 |
0 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
60.934 |
1.15E-179 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
56.713 |
7.42E-175 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
57.872 |
1.04E-168 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
51.277 |
2.93E-144 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
49.045 |
4.72E-142 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
48.832 |
2.39E-139 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
51.489 |
3.40E-139 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
46.253 |
1.19E-109 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
40.417 |
2.40E-98 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
40.881 |
4.48E-94 |
||
Cabbage |
CYP71A12 |
Cytochrome P450 71A12 |
41.387 |
2.99E-93 |
GO ID | Ontology | GO Term | Description |
---|---|---|---|
MF |
iron ion binding |
Interacting selectively and non-covalently with iron (Fe) ions. |
|
BP |
response to bacterium |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium. |
|
BP |
induced systemic resistance |
A response to non-pathogenic bacteria that confers broad spectrum systemic resistance to disease that does not depend upon salicylic acid signaling. |
|
CC |
membrane |
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
|
CC |
integral component of membrane |
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
|
MF |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from NADH or NADPH and one other donor, and one atom of oxygen is incorporated into one donor. |
|
MF |
oxygen binding |
Interacting selectively and non-covalently with oxygen (O2). |
|
MF |
heme binding |
Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring. |
|
BP |
secondary metabolite biosynthetic process |
The chemical reactions and pathways resulting in the formation of secondary metabolites, the compounds that are not necessarily required for growth and maintenance of cells, and are often unique to a taxon. |
|
BP |
oxidation-reduction process |
A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons. |